GlassScriptPhysician profile
Sarah Lee
NPI 1760866941
$1,951.87
in general payments reported to CMS, 2019-2025
14 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $515 · 2022: $433 · 2023: $186 · 2024: $297 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $826.85 | 2021-2022 | |
| Kerecis Limited | $243.90 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Axogen | $174.18 | 2023-2025 | Avance Nerve Graft |
| Smith+Nephew, INC. | $149.87 | 2024-2025 | Renasys Touch, Grafix Pl |
| Avita Medical Americas, LLC | $134.08 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Convatec INC. | $96.62 | 2023-2025 | |
| Kci USA, INC. | $95.63 | 2021 | |
| Solventum Corporation | $72.50 | 2025 | V.A.C. Veraflo Cleanse Choice, 3m Cavilon, Prevena |
| Mentor Worldwide LLC | $40.61 | 2024 | Artoura Breast Tissue Expander |
| Polynovo North America LLC | $38.81 | 2024 | Novosorb Btm |
| Opko Pharmaceuticals, LLC | $25.74 | 2021 | |
| Rti Surgical, INC | $24.24 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.14 | 2024 | Andexxa |
| Musculoskeletal Transplant Foundation INC. | $4.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.